Third-generation continuous-flow left ventricular assist devices: a comparative outcome analysis by device type.
Maks MihaljPaul Philipp HeinischPatrick SchoberMonika WieserMichele MartinelliTheo M M H de ByJoerg C SchefoldMarkus Martin LuediAlexander KadnerThierry CarrelPaul MohacsiLukas HunzikerDavid ReinekePublished in: ESC heart failure (2022)
Comparing midterm outcomes between HM3 and HW for LVAD support from a prospective registry, HW patients had a significantly higher risk of device malfunctions. No significant differences were evident between devices in overall survival and in respect to most outcomes.
Keyphrases
- left ventricular
- end stage renal disease
- newly diagnosed
- ejection fraction
- heart failure
- prognostic factors
- acute myocardial infarction
- type diabetes
- coronary artery disease
- patient reported outcomes
- adipose tissue
- acute coronary syndrome
- hypertrophic cardiomyopathy
- percutaneous coronary intervention
- left atrial
- left ventricular assist device
- aortic valve
- catheter ablation